Amabiotics is a biopharmaceutical company that develops innovative microbiome-derived medicines to fight age-related diseases. Our research focuses on Gut-Brain axis. AMABIOTICS’ lead candidate is AMA-101, a potential first-in-class therapy for Parkinson’s disease. We aim to satisfy unmet medical needs using microbiome-derived medicines and become the leading provider of therapeutics based on the human microbiome. Due to millions of years of coevolution, complex metabolic interactions exist between humans and their gut microbiota. Amabiotics uncovered a unique set of metabolites produced by healthy gut microbiota and involved in the maintenance of health.
Looking for a particular Amabiotics employee's phone or email?
Amabiotics Questions
1 people are employed at Amabiotics.
Amabiotics is based in Paris, Île-De-France.
Top Amabiotics Employees
-
Sofia B.
Senior Researcher at Amabiotics
New York, NY, US11
